Greater Occipital Nerve and Cervical Region Injection in Patients With Trigeminal Neuralgia
NCT ID: NCT04505280
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2020-07-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia
NCT04570293
The Effect of Intravenous Lidocaine on Trigeminal Neuralgia
NCT01955967
Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia
NCT06882525
Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain
NCT07250867
Pre Injection Use of Cryoanesthesia Versus Topical Anesthetic Gel in Reducing Pain Perception During Palatal Injections
NCT06165432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
%1 lidocaine injections to greater occipital nerve and cervical region once a week for 4 weeks
Lidocaine 1% Injectable Solution
Greater occipital nerve and cervical region injections once a week for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine 1% Injectable Solution
Greater occipital nerve and cervical region injections once a week for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Lutfi Kirdar Kartal Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cem Bölük
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Afyonkarahisar University of Health Sciences
Afyonkarahisar, Kartal/Soğanlık, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-KAEK-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.